(Q24292869)

ADAM metallopeptidase domain 9

1 reference

ADAM metallopeptidase domain 17

1 reference

metallopeptidase activity

1 reference

Beáta Szabó

3

Beáta

Szabó

1 reference

26 October 2023

Masashi Asai

1

Masashi

Asai

1 reference

26 October 2023

Chinatsu Hattori

2

Chinatsu

Hattori

1 reference

26 October 2023

Noboru Sasagawa

4

Noboru

Sasagawa

1 reference

26 October 2023

Kei Maruyama

5

Kei

Maruyama

1 reference

26 October 2023

Sei-ichi Tanuma

6

Sei-ichi

Tanuma

1 reference

26 October 2023

Shoichi Ishiura

7

Shoichi

Biochemical and Biophysical Research Communications

Ishiura

1 reference

26 October 2023

language of work or name

English

0 references

publication date

31 January 2003

0 references

published in

0 references

volume

301

0 references

page(s)

231-5

0 references

issue

1

0 references

cites work

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Amyloid plaque core protein in Alzheimer disease and Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Purification and cloning of amyloid precursor protein beta-secretase from human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

The ADAM gene family: surface proteins with adhesion and protease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

TACE and other ADAM proteases as targets for drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Human ADAM 12 (meltrin alpha) is an active metalloprotease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Processing of the notch ligand delta by the metalloprotease Kuzbanian

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Regulated cleavage of a contact-mediated axon repellent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

A secreted form of human ADAM9 has an alpha-secretase activity for APP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6

Alzheimer's disease: genes, proteins, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902999-6